Worth Venture Partners, LLC Kamada LTD Transaction History

Worth Venture Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$4.68 - $6.25 $728,764 - $973,243	-155,719 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$5.15 - $6.3 $537,644 - $657,701	104,397 Added 203.42%	155,719 $963,000
Q1 2018 May 11, 2018	SELL	$4.6 - $5.75 $480,226 - $600,282	-104,397 Reduced 67.04%	51,322 $236,000
Q4 2017 Feb 14, 2018	BUY	$4.35 - $5.15 $454,126 - $537,644	104,397 Added 203.42%	155,719 $1.97 Million
Q3 2017 Nov 07, 2017	BUY	$4.25 - $4.8 $218,118 - $246,345	51,322	51,322 $246,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $271M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.